Cargando…

Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality

People appear to vary in their susceptibility to lifestyle risk factors for cardiometabolic disease; determining a priori who is most sensitive may help optimize the timing, design, and delivery of preventative interventions. We aimed to ascertain a person’s degree of resilience or sensitivity to ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomares-Millan, Hugo, Poveda, Alaitz, Atabaki-Pasdar, Naemieh, Johansson, Ingegerd, Björk, Jonas, Ohlsson, Mattias, Giordano, Giuseppe N., Franks, Paul W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370461/
https://www.ncbi.nlm.nih.gov/pubmed/35956347
http://dx.doi.org/10.3390/nu14153171
_version_ 1784766805632352256
author Pomares-Millan, Hugo
Poveda, Alaitz
Atabaki-Pasdar, Naemieh
Johansson, Ingegerd
Björk, Jonas
Ohlsson, Mattias
Giordano, Giuseppe N.
Franks, Paul W.
author_facet Pomares-Millan, Hugo
Poveda, Alaitz
Atabaki-Pasdar, Naemieh
Johansson, Ingegerd
Björk, Jonas
Ohlsson, Mattias
Giordano, Giuseppe N.
Franks, Paul W.
author_sort Pomares-Millan, Hugo
collection PubMed
description People appear to vary in their susceptibility to lifestyle risk factors for cardiometabolic disease; determining a priori who is most sensitive may help optimize the timing, design, and delivery of preventative interventions. We aimed to ascertain a person’s degree of resilience or sensitivity to adverse lifestyle exposures and determine whether these classifications help predict cardiometabolic disease later in life; we pooled data from two population-based Swedish prospective cohort studies (n = 53,507), and we contrasted an individual’s cardiometabolic biomarker profile with the profile predicted for them given their lifestyle exposure characteristics using a quantile random forest approach. People who were classed as ‘sensitive’ to hypertension- and dyslipidemia-related lifestyle exposures were at higher risk of developing cardiovascular disease (CVD, hazards ratio 1.6 (95% CI: 1.3, 1.91)), compared with the general population. No differences were observed for type 2 diabetes (T2D) risk. Here, we report a novel approach to identify individuals who are especially sensitive to adverse lifestyle exposures and who are at higher risk of subsequent cardiovascular events. Early preventive interventions may be needed in this subgroup.
format Online
Article
Text
id pubmed-9370461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93704612022-08-12 Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality Pomares-Millan, Hugo Poveda, Alaitz Atabaki-Pasdar, Naemieh Johansson, Ingegerd Björk, Jonas Ohlsson, Mattias Giordano, Giuseppe N. Franks, Paul W. Nutrients Article People appear to vary in their susceptibility to lifestyle risk factors for cardiometabolic disease; determining a priori who is most sensitive may help optimize the timing, design, and delivery of preventative interventions. We aimed to ascertain a person’s degree of resilience or sensitivity to adverse lifestyle exposures and determine whether these classifications help predict cardiometabolic disease later in life; we pooled data from two population-based Swedish prospective cohort studies (n = 53,507), and we contrasted an individual’s cardiometabolic biomarker profile with the profile predicted for them given their lifestyle exposure characteristics using a quantile random forest approach. People who were classed as ‘sensitive’ to hypertension- and dyslipidemia-related lifestyle exposures were at higher risk of developing cardiovascular disease (CVD, hazards ratio 1.6 (95% CI: 1.3, 1.91)), compared with the general population. No differences were observed for type 2 diabetes (T2D) risk. Here, we report a novel approach to identify individuals who are especially sensitive to adverse lifestyle exposures and who are at higher risk of subsequent cardiovascular events. Early preventive interventions may be needed in this subgroup. MDPI 2022-08-01 /pmc/articles/PMC9370461/ /pubmed/35956347 http://dx.doi.org/10.3390/nu14153171 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pomares-Millan, Hugo
Poveda, Alaitz
Atabaki-Pasdar, Naemieh
Johansson, Ingegerd
Björk, Jonas
Ohlsson, Mattias
Giordano, Giuseppe N.
Franks, Paul W.
Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title_full Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title_fullStr Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title_full_unstemmed Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title_short Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
title_sort predicting sensitivity to adverse lifestyle risk factors for cardiometabolic morbidity and mortality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370461/
https://www.ncbi.nlm.nih.gov/pubmed/35956347
http://dx.doi.org/10.3390/nu14153171
work_keys_str_mv AT pomaresmillanhugo predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT povedaalaitz predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT atabakipasdarnaemieh predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT johanssoningegerd predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT bjorkjonas predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT ohlssonmattias predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT giordanogiuseppen predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality
AT frankspaulw predictingsensitivitytoadverselifestyleriskfactorsforcardiometabolicmorbidityandmortality